Skip to main content
. 2021 Jun 21;28:49. doi: 10.1186/s12929-021-00744-4

Fig. 5.

Fig. 5

Graphic representation of doxorubicin-liposome-microbubble complexes (DLMCs). In the presence of the US, DLMCs have facilitated the reversal of multidrug-resistant phenotypes and counteracted them in human breast cancer cells